Biogen Exercises Option to Increase Ownership in Samsung Bioepis, Biogen Will Pay Samsung BioLogics ~$700M To Increase Its Ownership In Samsung Bioepis To ~49.9%; Transaction To Close 2H Of 2018
Benzinga Newsdesk